Global GABA Supplements Market by Form (Capsules, Lozenges, and Powder)
Industry: Food and Beverages
Published Date: March-2023
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 250
Report ID: PMRREP33376
Newly-released GABA Supplements Market analysis report by Persistence Market Research reveals that global sales of GABA Supplement in 2022 were held at US$ 42 Million. With a projected growth of 5.7% from 2023 to 2033, the market is expected to reach a valuation of US$ 76 Million by the end of the forecast period. The market through Capsules is expected to be the highest revenue generator, projected to grow at a CAGR of over 5.3% from 2023 to 2033.
| Attributes | Details |
|---|---|
| GABA Supplements Market (2023) | US$ 43.5 Million |
| GABA Supplements Market (2033) | US$ 76 Million |
| GABA Supplements Market CAGR (2023 to 2033) | 5.7% |
| United States GABA Supplements Market CAGR (2023 to 2033) | 4.6% |
| Key Companies Covered |
|
As per the research of the GABA Supplements Market by Persistence Market Research - a market research and competitive intelligence provider, historically, from 2018 to 2022, the value of the market increased at around 3.5% CAGR. With an absolute dollar opportunity of US$ 32.5 Million, the market is projected to reach a valuation of US$ 76 Million by 2033.
The key drivers influencing the market’s expansion are its health benefits to provide relaxation to the brain resulting in reduced stress levels, improved sleep, and decreased anxiety and hormonal irritability.
According to the sleep foundation, it is estimated that around 30-48% of adults around the globe experience insomnia while around 10-30% of adults have chronic insomnia. In 2020, it was estimated that over 70% of Japanese people were not getting satisfactory sleep.
This number was around 60% for countries like the United States., the United Kingdom, and South Korea. With a higher number of sleep dissatisfaction and insomnia around the globe, the need for dietary supplements promoting relaxation and better sleep is expected to gain demand, creating an opportunity for GABA supplements.
According to WHO, Covid-19 had a significant impact on the world’s mental health. The number of people dealing with anxiety and depression went up to 25% globally. This created an opportunity for dietary supplements to promote relaxation and help reduce anxiety. GABA supplements are providing neurotransmitter support which can gain demand as dietary supplements to reduce anxiety.
Premenstrual dysphoric disorder (PMDD) is a prominent issue in women as around 6 million women face anxiety, depression, mood swings, and irritability. This condition can be helped with dietary supplements reducing anxiety and promoting better mood. This can significantly gain demand for GABA supplements as they are associated with mental wellness and also reduce inflammation.
In 2021, WHO estimated that around 1.3 billion adult population between ages 30 to 79 globally had hypertension. Over 45% of adults had undiagnosed hypertension, which significantly increased risks of strokes, heart failure, and other potential health problems. A study concluded that people consuming 80 milligrams of GABA had a significant drop in blood pressure. This health benefit of GABA supplements can gain demand to stabilize blood pressure levels in the market.
People with underlying medical conditions such as Parkinson’s disease, hyperactivity disorder, and seizure disorders may have lower GABA levels in their bodies. GABA supplements in these cases can provide additional support by producing calming effects to reduce anxiety.
Companies selling these supplements are having stress-measuring tests and FAQs on their websites to help consumers choose the best supplements for their requirements.
North America is a prominent market for GABA Supplement, with a market size of US$ 17.3 Million in 2022 and it is estimated to reach US$ 18 Million in 2023. It is projected that North America will have a market worth US$ 31.4 Million in 2033.
In 2022, it was estimated that over 21% of Americans experienced insomnia every single night and about 36% of US adults struggle to sleep at least once a week. In 2019, about 1 in 2 adults in Canada had trouble sleeping, while about 1 in 5 adults feel tired after sleep and 1 in 3 adults faced difficulty staying awake during the day.
Canada is also noted to have over 36% of adults inflicted with chronic stress associated with their lack of sleep. These significantly high numbers in the North American region can result in the demand for GABA supplements in the market to reduce stress levels and improve sleep quality.
United States GABA Supplements Market Analysis:
The market in the United States is expected to grow to be worth US$ 24.5 Million with an absolute dollar growth of US$ 8.9 Million between 2023 and 2033. The market in the United States has grown at a CAGR of 2.1% from 2018 to 2022 and is expected to grow at a CAGR of 4.6% from 2023 to 2033.
Anxiety disorder is one of the most common mental health issues in the U.S. with around 40 million adults suffering every year. The disorder is treatable yet only around 37% of people are actually receiving treatment. This can lead to people preferring dietary supplements to deal with anxiety in the United States creating a growth opportunity for GABA supplements.
United Kingdom GABA Supplements Market Analysis:
The market in the United Kingdom is expected to grow to be worth US$ 3.8 Million with an absolute dollar growth of US$ 1.4 Million. The market in the United Kingdom has grown at a CAGR of 2.4% from 2018 to 2022 and is expected to grow at a CAGR of 4.9% from 2023 to 2033.
Covid-19 had a significant effect on the number of people in the United Kingdom dealing with anxiety and depression. This led to people buying sleeping pills and anxiety medications illegally. For instance, in 2020 the consumption of sleeping pills increased by around 25% compared to 2019. GABA dietary supplements can provide a solution to this problem as they can be a non-harmful substitute for sleeping pills and can be purchased without a subscription.
Japan GABA Supplements Market Analysis:
In Japan, the market is expected to grow to be worth US$ 5.5 Million with an absolute dollar growth of US$ 2.2 Million till 2033. The market in Japan has grown at a CAGR of 2.8% from 2018 to 2022 and is expected to grow at a CAGR of 5.2% from the year 2023 to 2033.
In 2018, a survey study revealed that over 49% of people in Japan were dealing with insomnia. Further, in 2022, Japanese people searched online for sleeping solutions around 54 times per 100K people which was 15 times more than the average global search of about 3.6. This indicates that sleep disorders in Japan are a significant problem. To deal with this problem GABA dietary supplements are expected to gain growth in the projected period in Japan.
China GABA Supplements Market Analysis:
In China, the market is expected to grow to be worth US$ 6.5 Million by 2033 with an absolute dollar growth of US$ 3.1 Million from 2023 to 2033. The market has grown at a CAGR of 4.9% from 2018 to 2022 and is expected to grow at a CAGR of 6.7% from the year 2023 to 2033.
In 2018, around 300 million people in China were reportedly suffering from sleep disorders. Further, in 2022 the survey concluded that the situation is not getting any better with more than three out of four people in the country suffering from sleep problems. This growth can significantly influence people to purchase dietary supplements for better sleep, creating opportunities for GABA supplement demand in the country.
South Korea GABA Supplements Market Analysis:
The market in South Korea is expected to grow to be worth US$ 3 Million with an absolute dollar growth of US$ 1.4 Million. The market in the country has grown at a CAGR of 4.2% from 2018 to 2022 and is expected to grow at a CAGR of 6.1% from 2023 to 2033.
In 2018, South Korea had a significant suicide rate compared to other OECD (Organization for Economic Cooperation and Development) countries, and the nation marked around 40 deaths by suicide every day. It was estimated that around 95% of Koreans were dealing with stress and about 33% of them had chronic stress conditions. This condition is expected to influence people towards stress reduction and relaxation GABA supplements in the market.
South Korea is renowned throughout the world for its skincare products and innovative products to promote skin health. The use of supplements for skin care is also a growing trend in Korea as good sleep is also associated with skin benefits and general wellness. Brands like Amorepacific have launched GABA supplements to support beauty sleep.
Which Form of GABA Supplements Market is Projected to Witness the Significant Growth?
Demand for GABA Supplements in the form of capsules is projected to witness significant growth as it has grown at a CAGR of 3.4% from 2018 to 2022 and is expected to grow at a CAGR of 5% from 2023 to 2033.
Key players in the GABA Supplements Market are Now Foods, Horbaach, Pure Encapsulations, Thorne, Vitanica, Nutrabio, Country Life, Integrative Therapeutics, Solgar, and Nusa Pure.
The companies are manufacturing GABA supplements in the form of capsules, lozenges, powder, and gummies. The company website also features stress tests and quizzes to help consumers understand their dietary supplement needs.
By Form:
By Distribution Channel:
By Region:
To know more about delivery timeline for this report Contact Sales
The market is estimated to be valued at US$ 43.5 Million in 2023.
The market was reported at US$ 42 Million in 2022.
The market is expected to reach a valuation of US$ 76 Million in 2033.
The market registered a CAGR of 3.5% over the last 4 years.
The market is projected to witness a CAGR of 5.7% from 2023 to 2033.
The capsule supplement is projected to witness large demand till 2033 with expected growth at a CAGR of 5.3% by 2033.
The United States is projected to witness a market size of US$ 24.5 Million and is expected to grow at a 4.6% CAGR till 2033.
Key players in the market are Now Foods, Horbaach, Pure Encapsulations, Thorne, Vitanica, Nutrabio, Country Life, Integrative Therapeutics, Solgar, and Nusa Pure.
